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Myoclonus in Adult 
Huntington's Disease 
Caryn M. Vogel, MD," Ivo Drury, MB, HCh," 
L. Cass Terry, MD, PhD,t 
and Anne B. Young, MD, PhD* 
Two brothers with clinically definite adult Hunting- 
ton's disease developed disabling myoclonus years after 
the  first signs of the disease. Thei r  electroencepha- 
lograms were consistent with a primary generalized 
epilepsy, although neither man had seizures. The rnyo- 
clonus was controlled with valproic acid therapy. 
Vogel CM, Drury I, Terry LC, Young AB. 
Myoclonus in adult Huntington's disease. 
Ann Neurol 1991;29:213-215 
Myoclonus is an uncommon clinical feature in Hunt -  
ington's disease (HD). The prominent  movement  dis- 
order in affected adults is chorea, whereas in  juvenile 
patients, the clinical picture is o n e  of parkinsonism { 1, 
2). Only  3 patients with myoclonus complicating adult 
HD have been  reported [2-43, although t h e  preva- 
lence of m y o d o n u s  may be greater in  patients with 
juvenile onset  C1, 51. The patients described here illus- 
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trate that myoclonus can be a disabling but  treatable 
feature in a subset of patients with adult HD. 
Patient Histories 
T.T. was first evaluated at age 28 years, 2 years after the 
onset of cognitive decline and incoordination. The diagnosis 
of HD was supported by findings of dementia and chorei- 
form movements, and a definite family history of adult onset 
dementia and chorea previously diagnosed as HD (Fig 1). 
Neuropsychometric testing revealed a full scale I Q  (FSIQ) of 
72, and positron emission tomography (PET) demonstrated 
hypometabolism in the caudate nuclei. Ceruloplasmin, serum 
and urine copper levels, electroencephalogram (EEG), head 
computed tomographic (CT) scan, and cerebrospinal fluid 
(CSF) analysis were normal. Serial examinations over the 
next 5 years demonstrated only a mild cognitive decline until 
he presented with a I-month history of uncontrollable brief, 
rapid jerking movements. Examination revealed frequent 
generalized myoclonic jerks involving axial and appendicular 
muscle groups, exacerbated by any attempt at movement, 
and prominent rigidity. Benztropine mesylare and halo- 
peridol had been started after the onset of the myoclonus. 
These drugs were discontinued without clinical change. 
A head CT scan showed prominent caudate atrophy. An 
EEG demonstrated generalized bisynchronous polyspike 
waves, at times associated with myoclonic jerks, without loss 
of consciousness and enhanced by photic stimulation (Fig 2). 
The myoclonus, as recorded by surface electromyography 
over the right forearm, consisted of 40 to 80-msec bursts. 
The cortical component of short latency somatosensory 
evoked responses (SSERs) was not enlarged. An eccrine 
sweat gland biopsy for inclusion bodies, a periodic acid-Schiff 
stain for inclusion bodies in lymphocytes, an ophthalmolog- 
ical examination for a cherry red spot, and a lysosomal en- 
zyme screen were negative. He did not cooperate with for- 
mal neuropsychometric testing. 
Valproic acid was instituted daily with a pronounced re- 
duction in myoclonus and a return to his previous level of 
function. Follow-up examination 5 months later revealed 
rare myoclonus and no polyspike-wave activity on EEG. 
W.T., the older brother ofT.T., was diagnosed with HD at 
age 30 years, 2 years after the onset of cognitive decline and 
involuntary movements. His initial evaluation was similar to 
his brother's except for caudate atrophy on head CT scan. 
Five years later, his caretakers reported a progressive decline 
in ambulation and recent onset of jerking movements that 
were worse on awakening. O n  neurological examination, any 
attempt to walk brought out myoclonic movements, which 
were otherwise infrequent. An EEG showed bisynchronous 
polyspike waves enhanced by photic stimulation. These ap- 
peared both independent of and concomitant with the myo- 
clonus. The cortical component of the SSERs was not en- 
larged. Skin and rectal biopsies for inclusion bodies were 
negative by light and electron microscopy. Repeat neuro- 
psychometric testing revealed a FSIQ of 64, with a pro- 
nounced decline in motor speed and dexterity. Five months 
after starting valproic acid therapy, he could walk unassisted; 
however, the remainder of his neurological examination, in- 
cluding the chorea, was unchanged. Follow-up EEG con- 
tinued to show generalized polyspike waves. An EEG and 
SSERs were normal in a clinically unaffected brother. 
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F i g  1. Family pedigree. Solid black squares = definite Hunt- 
ingtoni- disease (HD); shaded squares = possible HD. 
Pig 2. Generali~edpo~spie-uia~le discharges accentuated by pho- 
tic stimulation in T.T. before treatment. 
Discussion 
These brothers are similar to the 3 previously reported 
patients with adult HD with myoclonus [a-41. In all 
these patients, myoclonus was precipitated by the initi- 
ation of voluntary movement and often appeared as 
massive sudden jerks involving axial and appendicular 
muscle groups, and was easily controlled by either val- 
proic acid or clonazepam. Each patient inherited HD 
from his father, and the onset of symptoms appeared 
in the third or  early fourth decade. 
Hereditary syndromes of myoclonus, dementia, and 
chorea comprise a rare and heterogenous group of dis- 
orders. In addition to HD, the differential diagnosis 
includes storage disorders (e.g., Lafora body disease, 
and neuronal ceroid lipofuscinosis and sialidosis), mi- 
tochondrial encephalomyopathies (e.g., myoclonic 
epilepsy and ragged red fibers, and "Tweed Ball" 
mitochondropathy), inborn errors of metabolism (e.g., 
glutaric acidemia, sulfite oxidase deficiency, and Lesch- 
Nyham syndrome), Wilson's disease, chorea-acantho- 
cytosis, and a few clinically or pathologically defined 
progressive myoclonic epilepsies (Unverricht-Lund- 
borg disease, May-White syndrome, Hallervorden- 
Spatz disease, dentatorubralpallidoluysian atrophy, 
neuronal axonal dystrophy, action myoclonus-renal 
failure syndrome [S-81). These brothers, however, 
lacked the inheritance pattern and clinical, laboratory, 
or pathological findings specific to these disorders. The 
autosomal dominant transmission, adult onset of cho- 
rea and dementia, and highly characteristic PET and 
CT findings strongly support HD as the clinical diag- 
nosis in this family and the previously reported patients. 
The electrophysiological features present in these 
patients are most consistent with reticular reflex myo- 
clonus, which has been characterized as a fragment of 
generalized epilepsy [9]. There was an identifiable 
EEG correlate in the form of generalized polyspike 
waves that was not time-locked to the myoclonus. The 
cortical component of the SSERs was normal. Al- 
though these brothers did not have generalized sei- 
zures, their EEGs were similar to those seen in patients 
with a primary generalized seizure disorder, and 2 of 
the 3 previously reported patients with adult HD with 
myoclonus had documented seizures. Seizures occur 
rarely in patients with adult HD, compared with mo- 
thirds of the patients with juvenile HD {If. 
Deficiencies in gamma-aminobutyric acid (GABA) 
activity may play a role in the pathogenesis of some 
types of myoclonus. Reduced levels of GABA are 
present in the CSF of patients with postanoxic myo- 
clonus and progressive myoclonic epilepsies compared 
with controls consisting of patients suffering from 
other neurological disorders [lo, 1 l}. The photosensi- 
tive myoclonus in the Senegalese baboon Pupio pupio 
can be blocked by gamma-acetylenic GABA and 
gamma-vinyl GABA, irreversible inhibitors of the 
degrading enzyme, GABA-transaminase [12). The 
manipulation of GABA activity in the contralateral 
striatum of rats results in sustained focal myoclonic 
jerks [l 3). Clonazepam and valproic acid, effective 
treatments of myoclonus due to diverse pathologies, 
exert their therapeutic effects at least in part by in- 
fluencing the GABA system [14}. 
In patients with rigid or juvenile onset HD, the 
denervation in the substantia nigra pars reticulata is 
profound fl5-j. Bilateral lesions of the reticulata or 
inhibition of the reticulata neurons by GABA agonists 
attenuate kindled seizures in rats [16]. Stimulation of 
the substantia nigra pars reticdata neurons or injection 
of GABA antagonists lower the seizure threshold in a 
similar animal model [17]. This loss of nigral inhibition 
from the striatum may play a role in the susceptibility 
to myoclonus or seizures of some patients with HD. 
If deficiencies in GABA are central to the patho- 
genesis of both HD and some forms of myoclonus, it is 
unclear why myoclonus is so infrequent in adult HD. 
HD is genetically homogeneous, with the gene lo- 
caked to the short arm of chromosome 4 [l81. Fur- 
ther studies will be necessary to elucidate why this 
population of patients with HD manifests a different 
expression of the same gene. Myoclonus should be 
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recognized as a treatable feature in some patients with 
adult HD. 
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Continuous Muscle Fiber 
Activity, Peripheral 
Neuropathy, and Thymoma 
A. Garcia-Merino, MD,” A. Cabello, MD,? J. S. Mora, MD,” 
and H. Liatio. MU” 
Two patients, one of them with myasthenia gravis, pre- 
sented symptoms of continuous muscle fiber activity syn- 
drome before discovery of a thymoma Peripheral neu- 
ropathy was present in both patients, with axonal and 
demyelinating lesions in sural nerve biopsy. The  syn- 
drome remained unchanged or worse after thymectomy. 
Both patients died of associated complications. 
Garcia-Merino A, Cabello A, Mora JS, Liafio H. 
Continuous muscle fiber activity, peripheral 
neuropathy, and thymoma. 
Ann Neurol 1991;29:215-218 
The syndrome of continuous muscle fiber activity at 
rest (CMFAS) [ 1 J associates a wide spectrum of clinical 
manifestations with spontaneous electromyographic 
(EMG) discharges. The  condition is a polymorphous 
entity described under various names such as neuro- 
myotonia, pseudomyotonia, Isms’  syndrome, and 
CMFAS {2). We  report here two patients with 
CMFAS, thymoma, and peripheral neuropathy, an as- 
sociation previously not recognized. The  purpose of 
this report is to draw attention to the possible rele- 




A 56-year-old, previously healthy woman began to note facial 
twitching, blurred vision, occasional trismus, and soon after, 
vague thoracic discomfort. Six months after onset of symp- 
toms, a large lymphoepithelial thymoma was found and re- 
sected. A few days after surgery, she developed profuse 
sweating, widespread muscle twitching, dyspnea, and carpal 
spasms. Serum calcium and magnesium were normal and in- 
travenous calcium did not modify the spasms, which were 
only relieved by diazepam. Her condition deteriorated pro- 
gressively. Her dyspnea became present on minimal effort 
and she developed laryngeal stridor. Extensor spasms of the 
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